Adverse Clinical Events Reported During HU Therapy
Type of Adverse Event . | No. of Events . | No. of Patients . |
---|---|---|
Sickle cell-related events | ||
Vasoocclusive pain | 76 | 34 |
ACS | 10 | 8 |
Gallstones | 1 | 1 |
Priapism | 1 | 1 |
Splenic sequestration | 1 | 1 |
Transient ischemic attack | 1 | 1 |
Other clinical events | ||
Pain3-150 | 50 | 29 |
Nausea/vomiting | 25 | 17 |
Infection | 23 | 20 |
Headache | 13 | 12 |
Diarrhea | 7 | 6 |
Skin rash | 7 | 5 |
Bleeding | 2 | 1 |
Growth failure | 0 | 0 |
Type of Adverse Event . | No. of Events . | No. of Patients . |
---|---|---|
Sickle cell-related events | ||
Vasoocclusive pain | 76 | 34 |
ACS | 10 | 8 |
Gallstones | 1 | 1 |
Priapism | 1 | 1 |
Splenic sequestration | 1 | 1 |
Transient ischemic attack | 1 | 1 |
Other clinical events | ||
Pain3-150 | 50 | 29 |
Nausea/vomiting | 25 | 17 |
Infection | 23 | 20 |
Headache | 13 | 12 |
Diarrhea | 7 | 6 |
Skin rash | 7 | 5 |
Bleeding | 2 | 1 |
Growth failure | 0 | 0 |
Pain reported by the patient that was not felt to be related to complications of sickle cell anemia by the patient and staff at participating center.